SI-BONE is a medical device company. Co. has a proprietary minimally invasive surgical implant system, which it calls iFuse, to address sacroiliac joint dysfunction and degeneration, adult deformity, pelvic ring traumatic fractures. Co.'s iFuse Implant System includes a series of patented triangular implants and the instruments Co. has developed to enable surgeons to perform the procedures using different surgical approaches for different indications. Co. has introduced iFuse-3D, its other implant. This patented titanium implant combines the triangular cross-section of the iFuse Classic implant with the proprietary 3D-printed porous surface and a fenestrated design. The SIBN average annual return since 2018 is shown above.
The Average Annual Return on the SIBN average annual return since 2018 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether SIBN average annual return since 2018 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the SIBN average annual return calculation with any dividends reinvested as applicable (on ex-dates).
|